Table 1.
Patient characteristics. NSCLC = non-small cell lung cancer.
| NSCLC (N = 10) | Head and neck (N = 10) | Lymphoma (N = 10) | Advanced cancers (N = 10) | |
|---|---|---|---|---|
| Sex—n (%) | ||||
| Male | 6 (60%) | 6 (60%) | 6 (60%) | 8 (80%) |
| Female | 1 (10%) | 4 (40%) | 4 (40%) | 2 (20%) |
| Not provided | 3 (30%) | 0 (0%) | 0 (0%) | 0 (0%) |
| Age—year | ||||
| Median (range) | 61 (47, 69) | 58 (48, 66) | 51 (36, 74) | 67 (48, 77) |
| Disease stage | ||||
| 1 | 0 | 0 | 1 | 0 |
| 2 | 1 | 2 | 1 | 0 |
| 3 | 6 | 2 | 1 | 2 |
| 4 | 0 | 6 | 7 | 8 |
| Not provided | 3 | 0 | 0 | 0 |
| Treatment | Platinum-based chemoradiotherapy without surgery | Chemoradiotherapies, various | Rituximab plus chemotherapies | Various (Lu-radiopharmaceutical therapies, hormonal therapy, immunotherapies, chemotherapies) |
| Time between scans—days | ||||
| Median (range) | 162 (82, 210) | 172.5 (102, 312) | 115 (44, 156) | 95 (0, 912) |